APA (7th ed.) Citation

T, P., I, G., LM, N., E, P., IR, M., J, B., . . . JS, D. (2014). Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia. Science translational medicine, 6(236), 236ra62. https://doi.org/10.1126/scitranslmed.3008661

Chicago Style (17th ed.) Citation

T, Perova, et al. "Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-risk Precursor B Cell Acute Lymphoblastic Leukemia." Science Translational Medicine 6, no. 236 (2014): 236ra62. https://doi.org/10.1126/scitranslmed.3008661.

MLA (9th ed.) Citation

T, Perova, et al. "Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-risk Precursor B Cell Acute Lymphoblastic Leukemia." Science Translational Medicine, vol. 6, no. 236, 2014, p. 236ra62, https://doi.org/10.1126/scitranslmed.3008661.